Wednesday, August 17, 2022
Advertisementspot_imgspot_img
HomeHealthCoronavirus UpdatesTrial for COVID-19 drug has started in Nigeria, says WHO

Trial for COVID-19 drug has started in Nigeria, says WHO

The World Health Organisation (WHO) has said the solidarity trial for a drug to treat COVID-19 has commenced in Nigeria, the world most populous black nation.

Officer in charge of WHO in Nigeria, Fiona Braka, who stated this while speaking on Friday at the joint national briefing of the presidential task force (PTF) on COVID-19, however, said the trials are still at an early stage.

In April, Nigeria had expressed interest to be part of the global solidarity drug trial to combat the disease which has infected close to 6,000 people in the country and 4.8 million globally.

Braka further stated that while the process has commenced in some states in the country, the trial is yet to begin in other states.

“This is a large multi-country effort that is going on globally. And we are picking up that trial in Nigeria; some states have started, some are yet to start,” she said.

“The whole idea is that the large pool of information across the countries will be systematically analysed at global level in addition to what is coming from other countries; carefully analysed and guidance provide to countries on which formulation is more effective.”

Read COVID-19: Work closely with PTF, Buhari tasks Nigerian governors

The WHO official said the drugs being tested are not new, but the ones already manufactured.

“They are simply being repurposed for the intention of determining their effects on the COVID virus,” she said.

“We will continue to keep you updated on what the timeline will look like but we are still quite early in the process in the collection of data.”

RELATED ARTICLES
- Advertisment -

Most Popular

Recent Comments